Harvard Mental Health Letter Editorial Board

Michael Craig Miller, MD, Editor in Chief:
Dr. Miller is an Assistant Professor of Psychiatry at Harvard Medical School and Editor in Chief of the Harvard Mental Health Newsletter.

Mary Anne Badaracco, MD:
Dr. Mary Anne Badaracco is the Chief of Psychiatry at the Beth Israel Deaconess Medical Center and board certified in adult and child psychiatry. She received her AB from St. Louis University and her MD from Harvard Medical School. Dr. Badaracco is also a graduate of the Psychoanalytic Institute of New England, East.

Dr. Badaracco has held several other positions including Director of Child Psychiatry Training and Director of Hospital Services at Massachusetts Mental Health Center. She was also the Director of Inpatient Psychiatry at Deaconess Hospital, prior to becoming the Associate Chief of Psychiatry at the Beth Israel Deaconess Hospital.

Child Psychopharmacology, the developmental aspects of affective disorders, inpatient psychiatry, and psychiatric training are areas of particular interest to Dr. Badaracco.

Dr. Badaracco is currently the President of the MPS.

Jonathan F. Borus, MD:
Jonathan F. Borus is the Stanley Cobb Professor of Psychiatry at Harvard Medical School and since 1990 has been Chairman and Psychiatrist in Chief of the Department of Psychiatry at the Brigham and Women's/Faulkner Hospitals. From 1976-90 he was the Director of Psychiatry Residency and Fellowship Training at the Massachusetts General Hospital and for the last seven of those years also served as Chair of the Hospital's Committee on Teaching and Education. A founder of the award-winning Harvard Longwood Psychiatry Residency Training Program and a Distinguished Life Fellow of the American Psychiatric Association, Dr. Borus has served as the President of the Association for Academic Psychiatry, the national organization of psychiatric educators, and Editor of the journal Academic Psychiatry. He has been honored with the 1992 Outstanding Psychiatric Educator Award from the Association for Academic Psychiatry, the1997 Vestermark Award for Psychiatric Education from the American Psychiatric Association and the National Institute of Mental Health, the 1998 Harvard Medical School Lifetime Achievement Award for Excellence in Mentoring, and the 2004 Lifetime Achievement in Education Award from the Association for Academic Psychiatry. A practicing psychiatrist who works at the interface of psychiatry with medicine, Dr. Borus is double-Boarded in general psychiatry and forensic psychiatry and maintains a clinical practice working primarily with physicians experiencing difficulties in their lives, and with dual career couples.

Christopher B. Daly:
Mr. Daly is a Visiting Professor of Journalism at Boston University.

Frank W. Drislane, MD:
Frank Drislane is an Associate Professor of Neurology at Harvard Medical School and a neurologist at Beth Israel Deaconess Medical Center in Boston. He is the director of the Neurology residency program at BIDMC and of the clerkship in Neurology at BIDMC for Harvard Medical students. He serves on the board of the American Clinical Neurophysiology Society, and for the examinations of the American Board of Clinical Neurophysiology, and on committees for the American Epilepsy Society. He is an associate editor of the Harvard Mental Health Letter. He is a graduate of Dartmouth College and Yale Medical School.

Dr Drislane is a practicing neurologist with a subspecialty interest in epilepsy and teaches on the clinical service in general Neurology and in the Comprehensive Epilepsy Center at Beth Israel Deaconess Medical Center. His research and writing are primarily in the areas of refractory seizure disorders and particularly, status epilepticus.

Anne K. Fishel, PhD:
Dr. Anne Fishel is an Assistant Professor of Psychology at the Harvard Medical School, and the Director of the Family and Couples Therapy Program at MGH. Dr. Fishel graduated magna cum laude from Harvard University, and received her Ph.D. from the University of North Carolina at Chapel Hill. She completed an internship and post-doctoral fellowships at Massachusetts General Hospital and Judge Baker Guidance Center. She is the author of a book, Treating the Adolescent in Family Therapy: A Narrative and Developmental Approach, published by Jason Aronson in 1999, as well as numerous articles and book chapters on couples and family therapy. Her research interests lie in the area of IVF couples, transition to parenthood, and the use of the reflecting team as a clinical and training tool. The recipient of multiple teaching awards from the Psychology, Adult Psychiatry, and Child Psychiatry Departments, she gives many local and national talks on family therapy. She has worked as a consultant to several clinics, training mental health staff in narrative therapy and the reflecting team. Dr. Fishel is a member of the American Family Therapy Academy and an elected member of Woman in Academic Medicine at MGH.

Donald C. Goff, MD:
Dr. Donald C. Goff is Director of the Schizophrenia Clinical and Research Program at Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School. In addition, he is Director of Schizophrenia Research and Medical Director of the Freedom Trail Clinic at the Erich Lindemann Mental Health Center in Boston.

Dr. Goff earned his undergraduate degree in humanities at the University of California in Berkeley, and his medical degree at the University of California School of Medicine in Los Angeles. After graduating, he completed his internship in internal medicine at Cedars Sinai Medical Center in Los Angeles, and his residency in psychiatry at Massachusetts General Hospital in Boston. His research fellowship in psychopharmacology was completed at Tufts-New England Medical Center, also in Boston.

Dr. Goff has authored and co-authored numerous articles concerning schizophrenia and related topics. His articles are published in prestigious journals, such as Archives of General Psychiatry, American Journal of Psychiatry, and Journal of the American Medical Association. Dr. Goff established the Schizophrenia Program at the Massachusetts General Hospital in 1988, which has grown under his leadership to include ten independent investigators studying pharmacology, genetics, neuroimaging, wellness, and cognitive behavioral therapy.

Dr. Goff is a recipient of the Faculty Scholar Award in Schizophrenia and a Mid-Career Development Award presented by the National Institute of Mental Health, and the Kempf Award for Mentorship in Biological Psychiatry from the American Psychiatric Association. Dr. Goff is a member of the American College of Neuropharmacology.

Jack M. Gorman, MD:
Jack M. Gorman, M.D., is a Professor in the Department of Psychiatry at Mount Sinai School of Medicine in New York City. He is also the Scientific Director of the Phobia, Anxiety, and Stress Disorders Clinic at Long Island Jewish Medical Center.

Dr. Gorman earned his medical degree at the College of Physicians and Surgeons, Columbia University. He then interned in pediatrics at Babies Hospital in New York City, and completed a residency in psychiatry at the New York State Psychiatric Institute and Columbia-Presbyterian Medical Center. He also completed a fellowship in psychiatric research and psychopharmacology at Columbia University. He is a Fellow of the American College of Neuropsychopharmacology, Past President of the American Psychopathological Association, Chair of the Scientific Advisory Council of the National Alliance for the Mentally Ill (NAMI), and was named one of the nine best adult psychiatrists in the United States by American Health Magazine. Dr. Gorman is the winner of the American Psychiatric Association Research Prize, the Gerald Klerman Lifetime Achievement Award of the National Depression and Manic Depression Association (DMDA), the Usdin Award of the West Coast College of Biological Psychiatry, and the Joel Elkes Award of the American College of Neuropsychopharmacology.

In addition to his two books both for the general audience (The Essential Guide to Psychiatric Drugs and The Essential Guide to Mental Health, both published by St. Martin's Press), he is the author of more than 350 journal articles and textbook chapters and co-editor of the textbook Treatments that Work. Dr. Gorman also serves as the deputy editor of the American Journal of Psychiatry, and as editor-in-chief of CNS Spectrums.

Alan I. Green, MD:
Dr. Alan I. Green is the Raymond Sobel Professor of Psychiatry, Professor of Pharmacology and Toxicology, and Chairman of the Department of Psychiatry at Dartmouth Medical School. A practicing psychiatrist, Dr. Green's research interests involve the biology of schizophrenia and substance abuse and the mechanisms of action of medications used to treat these disorders. He has written over 180 scientific articles, book chapters or research abstracts. He is a member of the American College of Neuropsychology and a Distinguished Fellow of the American Psychiatric Association.

William E. Greenberg, MD:
William Greenberg, MD is an Assistant Professor of Psychiatry at Harvard Medical School and on the staff of Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital in Boston. He has been a residency training director since 1987, first at Beth Israel Hospital and then, since 1994, at the Harvard Longwood Psychiatry Residency. He has served in leadership roles in local and national organizations involved with psychiatric education. His clinical practice is in general psychiatry.

Shelly F. Greenfield, MD, MPH:
Dr. Greenfield is Associate Professor of Psychiatry at Harvard Medical School and Associate Clinical Director of the Alcohol and Drug Abuse Treatment Program at McLean Hospital in Belmont, Massachusetts where she also directs the outpatient substance abuse treatment program and consultation services. Dr. Greenfield is the Director of the Harvard Medical School/Partners Addiction Psychiatry Fellowship and directs the substance abuse clinical rotations of the Adult Psychiatry Residency of the Massachusetts General and McLean Hospitals. Dr. Greenfield serves as Principal Investigator and Co-Investigator on federally funded research focusing on treatment for substance use disorders, gender differences in substance disorders, and health services for substance disorders. She is a past recipient of a National Institute on Drug Abuse (NIDA)-funded career award and is currently Principal Investigator of a NIDA-funded grant to design and pilot a new manual-based group therapy for women with substance use disorders. She is also co-Principal Investigator of the Northern New England node of the NIDA Clinical Trials Network. Dr. Greenfield served as the Founding Scientific Director of National Alcohol Screening Day, is past Chair of the American Psychiatric Association’s Council on Addiction Psychiatry, Chair of the NIDA Clinical Trial Network’s Gender Special Interest Group, and is Editor-in-Chief of the Harvard Review of Psychiatry. She has been elected to the American College of Psychiatrists and is a Distinguished Fellow of the American Psychiatric Association.

Thomas G. Gutheil, MD:
Dr. Gutheil is Professor of Psychiatry at Harvard Medical School, Associate Director of Medical Student Training and Co-director of the Program in Psychiatry and the Law at the Mass. Mental Health Center, where he has worked for a third of a century. He is the first Professor of Psychiatry in the history of the Harvard Medical School to be board certified in both clinical and forensic psychiatry. He is former Visiting Lecturer at Harvard Law School and Past Presdient of the American Academy of Psychiatry and Law. Recipient of every major award in the forensic field as well as multiple teaching and writing awards, Dr. Gutheil has served as an expert witness in 45 states.

In addition to maintaining a small private practice, Dr.Gutheil teaches internationally on forensic issues, malpractice prevention and risk management.. He is author or co-author of over two hundred articles in the national and international clinical and forensic literature and six books, with two more in preparation. He is the first psychiatrist to have won three times the Manfred S. Guttmacher award for outstanding contribution to the forensic psychiatric literature. He has been elected a Distinguished Fellow of the American Psychiatric Association.

Michael Hirsch, MD:
Michael Hirsch is an Instructor in Psychiatry at Harvard Medical School and Director of Psychopharmacology at Beth Israel Deaconess Medical Center in Boston. In addition to maintaining an active clinical practice, Dr. Hirsch writes and lectures on contemporary issues in the treatment of mental illness and teaches psychopharmacology to residents in the Harvard Longwood Psychiatry Resident Training Program.

Robert W. McCarley, MD:
Dr. McCarley is the Department Head of Harvard Department of Psychiatry and the VA Boston Healthcare System, the Deputy Chief of Staff for Mental Health Services and the VA Boston Healthcare System, the Head of Mental Health Services (Mental Health Service Line Manager) and Brockton VAMC, and the Manager of the Mental Health Care Line and the VA Boston Healthcare System.

Dr. McCarley’s career in basic research has focused on how the brain controls behavior, especially that of sleep and wakefulness. The rapid eye movement (REM) sleep phase is present in all mammals and is of special interest to psychology and psychiatry because of its relationship to dreaming and to mood disorder. Dr. McCarley’s work has been important in discovery of its brainstem control mechanisms, both its promotion by the reticular and cholinergic activity and its inhibition by aminergic activity. Still another line of work indicates adenosine acting in the basal forebrain is a key nonREM sleep factor, controlling the sleepiness that occurs after prolonged wakefulness. Recent work has focused on the second messenger and molecular consequences of elevated adenosine that may be useful in explaining “sleep debt”, the long-term consequences of sleep restriction/deprivation. Another line of recent work is describing how the neuropeptide orexin acts in the basal forebrain to promote wakefulness, and how interference with orexin action by antisense directed toward mRNA for brainstem reticular orexin II receptors increases REM sleep and causes behavioral cataplexy in animals.

Dr. McCarley’s career in clinical research has focused on neuroimaging and neurophysiology of schizophrenia. His work let to the heightened recognition of the auditory and language-related areas of the brain in the superior temporal gyrus as the site of MRI neuroantomic gray matter abnormalities (volume decreases compared with healthy controls) that were associated with clinical symptoms of formal thought disorder, as well as physiological and cognitive processing abnormalities indexed by the P300 evoked potential, including cognitive updating. Work in first episode patients has shown the specificity of these abnormalities to schizophrenic psychosis as contrasted with manic (affective) psychosis. Investigation of the schizophrenia spectrum disorder of schizotypal personality disorder (SPD) has shown these individuals share many of the MRI and evoked potential abnormalities referable to the superior temporal gyrus, thus clearly indicating a biological root of this personality disorder. Recent work suggests that the superior temporal gyrus gray matter volume reduction in schizophrenia is progressive over the year and a half following the first hospital admission for psychosis.

Dr. McCarley graduated Summa cum laude from Harvard College where he was elected to the Alpha Chapter of Phi Beta Kappa. Upon graduating from Harvard, he was a Fulbright Scholar in Psychology at Johannes Gutenberg Universitaet, Mainz, Germany for one year. He was a National Scholar at both Harvard College and Harvard Medical School. He interned at the Brigham and Women's Hospital in Boston, and began his research career while he was still a resident in psychiatry at the Massachusetts Mental Health Center (MMHC). Dr. McCarley was a National Institute of Mental Health Special Postdoctoral Fellow in the Laboratory of Neurophysiology, Harvard Medical School Department of Psychiatry at Massachusetts Mental Health Center. In this laboratory he began his fundamental research on the cellular physiology of sleep. He was named co-Director of the Laboratory of Neurophysiology in 1975. Dr. McCarley was promoted to the rank of Professor of Psychiatry in 1984, and in 1985 moved to the Harvard-affiliated Brockton/West Roxbury VA Medical Center where he established a new laboratory, the Laboratory of Neuroscience, whose basic studies science focus on the biology of sleep and whose clinical studies focus on neuroimaging in schizophrenia. Since 1994, he has served as Head of Mental Health Services and Chairman of the Harvard Department of Psychiatry at the Brockton/West Roxbury VA, now the VA Boston Healthcare System. From 1995-2002 he chaired the Harvard Department of Psychiatry Research Committee. From 2001-3 he was Co-Chair of the Harvard-wide Psychiatry Department Executive Committee

Dr. McCarley has been widely recognized and honored for his research in basic cellular neurophysiological and anatomical studies related to the control of behavioral states of sleep and wakefulness, as well as for his neuroimaging studies in schizophrenia.

He has received the top research prizes of the US Sleep Research Society, the American Psychiatric Association, and the United States Department of Veterans Affairs. He has published more than 250 peer-reviewed papers, 9 in Science, and has received consistent peer reviewed funding from the US NIH (currently 4 R01 awards) and VA Medical Research Service. His NIH awards include two consecutive 10 year MERIT awards for the study of sleep mechanisms.

Michael J. Mufson, MD:
Michael Mufson is an Assistant Professor of Psychiatry at Harvard Medical School. He is a staff psychiatrist at the Brigham and Women’s Hospital and Director of Psychiatry at the West Roxbury Veteran’s Administration Hospital where he has been on staff for over twenty years. During that time he has been intensively involved in the teaching of Harvard Medical School students and psychiatric resident and has won teaching awards in both of those settings.

A practicing psychiatrist, Dr. Mufson has an extensive clinical practice including patients with medical and psychiatric problems, complex psychopharmacologic issues, and sleep and pain disorders. He has clinical expertise in sleep disorders, pain disorders and diagnostic issues in complex medical psychiatric settings.

Andrew A. Nierenberg, MD:
Dr. Nierenberg is an Associate Professor of Psychiatry at Harvard Medical School and Associate Director of the Depression Clinical and Research Program and Medical Director of the Bipolar Programs at Massachusetts General Hospital.

Dr. Nierenberg has an active clinical practice that centers on the treatment of mood disorders. He has served as a reviewer for grants at the National Institute of Mental Health and is on the editorial board of 4 of the top 10 journals in psychiatry. He has published over 160 original articles, chapters, and reviews. His primary interests are treatment resistant depression, bipolar depression, juvenile bipolar disorder, and the longitudinal course of affective disorders. As an acknowledgment of his contributions to the field, Dr. Nierenberg received the prestigious 1999 Gerald L. Klerman Young Investigator Award from the National Depressive and Manic Depressive Association (now known as the Depression Bipolar Support Alliance). He was also elected as a member of the American College of Neuropsychopharmacology.

Hester H. Schnipper, LICSW, BCD:
Hester Hill Schnipper, LICSW, BSW is the Chief of Oncology Social Work at the Beth Israel Deaconess Medical Center and was the first Susan G. Komen Breast Cancer Foundation Survivorship Professor.

She has been a nationally respected clinician, teacher, and speaker in the field of psychosocial oncology for more than twenty-five years and has always been especially well known for her work with women who have breast cancer. Ms. Schnipper is a past President of the National Association of Oncology Social Workers.

Ms. Schnipper has written many professional articles and two books. Her first, Woman to Woman: A Handbook for Women Newly Diagnosed with Breast Cancer, was published in 1999. Her second book, After Breast Cancer: A Common Sense Guide to Life After Treatment was published by Bantam/Dell, New York in October 2003.

Barbara Wolfe, PhD, RN:
Barbara Wolfe is a Professor of Nursing at the William F. Connell School of Nursing at Boston College, and a faculty member of the Department of Psychiatry at Harvard Medical School and Beth Israel Deaconess Medical Center. She has been a member of the Eating Disorders Research Unit at Beth Israel Deaconess Medical Center for 15 years with a focus on the psychobiology of anorexia and bulimia nervosa. Dr. Wolfe is certified as an Advanced Practice Registered Nurse in the specialty of psychiatric-mental health nursing. She is a former President of the American Psychiatric Nurses Association and an elected Fellow in the American College of Nursing.